{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2014-11-20&_page=0&AnsweringBody.=Department%20of%20Health&_properties=answer.isMinisterialCorrection,tablingMember.label,tablingMember,date,hansardHeading&max-date=2019-05-21&_sort=-tablingMemberConstituency&max-answer.dateOfAnswer=2019-05-21", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?date=2014-11-20&AnsweringBody.=Department%20of%20Health&_properties=answer.isMinisterialCorrection,tablingMember.label,tablingMember,date,hansardHeading&max-date=2019-05-21&_sort=-tablingMemberConstituency&max-answer.dateOfAnswer=2019-05-21", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2014-11-20&_page=0&AnsweringBody.=Department%20of%20Health&_properties=answer.isMinisterialCorrection,tablingMember.label,tablingMember,date,hansardHeading&max-date=2019-05-21&_metadata=all&_sort=-tablingMemberConstituency&max-answer.dateOfAnswer=2019-05-21", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2014-11-20&_page=0&AnsweringBody.=Department%20of%20Health&_properties=answer.isMinisterialCorrection,tablingMember.label,tablingMember,date,hansardHeading&max-date=2019-05-21&_sort=-tablingMemberConstituency&max-answer.dateOfAnswer=2019-05-21", "isPartOf" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2014-11-20&AnsweringBody.=Department%20of%20Health&_properties=answer.isMinisterialCorrection,tablingMember.label,tablingMember,date,hansardHeading&max-date=2019-05-21&_sort=-tablingMemberConstituency&max-answer.dateOfAnswer=2019-05-21", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?date=2014-11-20&AnsweringBody.=Department%20of%20Health&_properties=answer.isMinisterialCorrection,tablingMember.label,tablingMember,date,hansardHeading&max-date=2019-05-21&_sort=-tablingMemberConstituency&max-answer.dateOfAnswer=2019-05-21", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2014-11-20&_page=0&AnsweringBody.=Department%20of%20Health&_properties=answer.isMinisterialCorrection,tablingMember.label,tablingMember,date,hansardHeading&max-date=2019-05-21&_sort=-tablingMemberConstituency&max-answer.dateOfAnswer=2019-05-21", "type" : "http://purl.org/linked-data/api/vocab#ListEndpoint"} , "items" : [{"_about" : "http://data.parliament.uk/resources/157008", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/157008/answer", "answerText" : {"_value" : "

The management of individual cases of E.coli<\/em> bloodstream infections is the responsibility of local infection prevention and control specialists. However, the Department has asked its expert Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infections to consider the options for reducing the number of E.coli<\/em> infections, which are not always hospital acquired.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"} } , "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"} , "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"} , "dateOfAnswer" : {"_value" : "2014-11-27", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-11-27T17:18:51.627Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-11-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "E. coli"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, if he will issue guidance to hospitals so that a case of E.coli bacteria triggers the procedures that would be followed if a case of MRSA were discovered.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4079", "label" : {"_value" : "Biography information for Julian Sturdy"} } , "tablingMemberConstituency" : {"_value" : "York Outer"} , "tablingMemberPrinted" : [{"_value" : "Julian Sturdy"} ], "uin" : "215426"} , {"_about" : "http://data.parliament.uk/resources/156993", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/156993/answer", "answerText" : {"_value" : "

Generally antibiotic use is determined locally and is driven by microbiology departments and by local antibiotic resistance patterns. There are two specific areas of specialised commissioning where provisions for antibiotics are relevant. A national policy for cystic fibrosis is already available (http://www.england.nhs.uk/wp-content/uploads/2013/04/a01-ps-a.pdf<\/a>) and a policy covering treatment of multi drug resistant tuberculosis (TB) is being developed. This new policy should be introduced from April 2015 and hopes to set policy for Bedaquiline and possibly Delamanid, two drugs recently launched into the United Kingdom market for multidrug resistant TB.<\/p>

<\/p>

<\/strong><\/p>

<\/p>

<\/strong><\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"} } , "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"} , "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"} , "dateOfAnswer" : {"_value" : "2014-11-25", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-11-25T17:35:36.03Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-11-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Antibiotics"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what guidance he issues on the commissioning of novel antibiotics designed to treat life-threatening infections at a national level through NHS England's specialised commissioning system.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4056", "label" : {"_value" : "Biography information for Nic Dakin"} } , "tablingMemberConstituency" : {"_value" : "Scunthorpe"} , "tablingMemberPrinted" : [{"_value" : "Nic Dakin"} ], "uin" : "215485"} , {"_about" : "http://data.parliament.uk/resources/156994", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/156994/answer", "answerText" : {"_value" : "

As part of the United Kingdom\u2019s antimicrobial resistance strategy, we have been working with industry and with other national and international stakeholders on how best to stimulate the development of new antibiotics, diagnostics and potential business models as well as on research into antimicrobial resistance.<\/p>

<\/p>

<\/p>

<\/p>

We will continue to explore what can be done to support antimicrobial diagnostics and drug development pending the announcement by the independent Review on Antimicrobial Resistance of its conclusions.<\/p>

<\/p>

<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2014-11-25", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-11-25T13:22:48.517Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-11-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Antibiotics"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, with reference to the Government's response to the House of Commons Science and Technology Committee report, Ensuring access to working antimicrobials, Cm, 8919, whether his Department is working on potential alternative pricing and reimbursement mechanisms for novel antibiotics in advance of the conclusion of the O'Neill Review; and what plans he has to explore new funding mechanisms with industry in the interim.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4056", "label" : {"_value" : "Biography information for Nic Dakin"} } , "tablingMemberConstituency" : {"_value" : "Scunthorpe"} , "tablingMemberPrinted" : [{"_value" : "Nic Dakin"} ], "uin" : "215487"} , {"_about" : "http://data.parliament.uk/resources/156998", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/156998/answer", "answerText" : {"_value" : "

Off-patent drugs are those whose patent period has expired and they are widely used in the National Health Service now. Drugs can also be prescribed \u2018off-label\u2019 outside of their licensed indication(s) to individual patients where doctors consider it is clinically appropriate to do so. Prescribing decisions are rightly a matter for clinicians in discussion with their patients.<\/p>

<\/p>

<\/p>

<\/p>

My Rt. hon. Friend the Secretary of State has had no discussions with charities about the use of off-patent drugs for new indications since 2 July. Officials have had several discussions with the Breast Cancer Campaign covering their views on medicines licences, implementation of National Institute for Health and Care Excellence guidelines and planning the roundtable discussion on adoption of new evidence into clinical practice. There have also been ongoing discussions with Cancer Research UK on the use of aspirin to help prevent certain cancers.<\/p>

<\/p>

<\/strong><\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2014-11-27", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-11-27T17:23:49.943Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-11-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs: Licensing"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, on what dates since 2 July 2014 he has discussed with charities the use of off-patent drugs for new indications; and what the content of these discussions was.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4133", "label" : {"_value" : "Biography information for Andrew Bridgen"} } , "tablingMemberConstituency" : {"_value" : "North West Leicestershire"} , "tablingMemberPrinted" : [{"_value" : "Andrew Bridgen"} ], "uin" : "215396"} , {"_about" : "http://data.parliament.uk/resources/157006", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/157006/answer", "answerText" : {"_value" : "

The Government is determined to make sure children and young people get the mental health care they need, and are taking a number of steps to address this.<\/p>

<\/p>

<\/p>

<\/p>

The Children and Young People\u2019s Mental Health and Wellbeing Taskforce was launched in August 2014 to look at how to improve children and young people\u2019s access to mental health services which are more responsive to their needs. It will focus on innovative solutions to improve access to help and support across the sectors, including in schools, through voluntary organisations and online. The Taskforce will report next spring.<\/p>

<\/p>

<\/p>

<\/p>

The Department has invested £7 million in new Children and Adolescent Mental Health Services specialised Tier 4 beds, £54 million into the Children and Young People\u2019s Improving Access to Psychological Therapies programme and £3 million in MindEd, which provides clear guidance on children and young people's mental health, wellbeing and development to any adult working with children, young people and families. The Department is seeking to procure a new survey of child and adolescent mental health. We are also introducing a new waiting time standard to make sure young people with psychosis get prompt treatment.<\/p>

<\/p>

<\/p>

<\/p>

Public Health England has recently published a framework that addresses the mental health of young people, commissioning the Institute of Health Equity to produce evidence based briefings on parenting programmes and publishing a briefing for head teachers which makes the link between education attainment and pupil health and wellbeing.<\/p>

<\/p>

<\/p>

<\/p>

Public Health England will also be publishing a framework for local authorities to improve health and wellbeing outcomes for young people aged 10 \u2013 24. In all these products, mental health and wellbeing are key features.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1439", "label" : {"_value" : "Biography information for Norman Lamb"} } , "answeringMemberConstituency" : {"_value" : "North Norfolk"} , "answeringMemberPrinted" : {"_value" : "Norman Lamb"} , "dateOfAnswer" : {"_value" : "2014-11-25", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-11-25T17:30:57.823Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-11-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mental Health Services: Young People"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what steps his Department is taking to improve mental health services for young people.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/69", "label" : {"_value" : "Biography information for Sir Oliver Heald"} } , "tablingMemberConstituency" : {"_value" : "North East Hertfordshire"} , "tablingMemberPrinted" : [{"_value" : "Sir Oliver Heald"} ], "uin" : "215408"} , {"_about" : "http://data.parliament.uk/resources/156991", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/156991/answer", "answerText" : {"_value" : "

The Law Commissions\u2019 review of the regulation of health professionals proposed that the third part (Specialist Community Public Health Nurse) of the Nursing and Midwifery Council\u2019s register should be removed and should be replaced with annotations to the register to denote those currently registered in the third part of the register. The Department is considering the Law Commission\u2019s proposals and is working closely with the regulatory bodies and the Professional Standards Authority to inform our response, which we will publish in due course. The Government\u2019s views on this, and all other recommendations made by the Law Commissions, will be outlined in this response.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"} } , "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"} , "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"} , "dateOfAnswer" : {"_value" : "2014-11-25", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-11-25T17:05:47.703Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-11-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Health Professions: Regulation"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, when he plans to publish his response to the Law Commission Review of the Regulation of Health Care Professionals published in April 2014; and what his policy is towards the proposal that the Nursing and Midwifery Council should close the specialist public health nursing part of their register.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4036", "label" : {"_value" : "Biography information for Luciana Berger"} } , "tablingMemberConstituency" : {"_value" : "Liverpool, Wavertree"} , "tablingMemberPrinted" : [{"_value" : "Luciana Berger"} ], "uin" : "215479"} , {"_about" : "http://data.parliament.uk/resources/157002", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/157002/answer", "answerText" : {"_value" : "

The Department is continuing negotiations with the manufacturer to seek to agree a cost-effective price for the supply of the meningococcal B vaccine, Bexsero. The negotiations will be completed as quickly as practicable.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2014-11-25", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-11-25T17:07:52.2Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-11-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Meningitis: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what steps he is taking to negotiate an agreement on the price of the vaccine for meningococcal B.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4036", "label" : {"_value" : "Biography information for Luciana Berger"} } , "tablingMemberConstituency" : {"_value" : "Liverpool, Wavertree"} , "tablingMemberPrinted" : [{"_value" : "Luciana Berger"} ], "uin" : "215474"} , {"_about" : "http://data.parliament.uk/resources/157001", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/157001/answer", "answerText" : {"_value" : "

We do not have an accurate estimate of the gender pay gap for employees of NHS England.<\/p>

<\/p>

<\/p>

<\/p>

NHS England does not have offices in Stoke Newington, Hackney North constituency, or Hackney local authority area.<\/p>

<\/p>

<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"} } , "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"} , "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"} , "dateOfAnswer" : {"_value" : "2014-11-27", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-11-27T17:21:57.823Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-11-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS England"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what estimate his Department has made of the gender pay gap for employees of NHS England in (a) Stoke Newington and Hackney North constituency, (b) Hackney local authority area, (c) London and (d) England; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/172", "label" : {"_value" : "Biography information for Ms Diane Abbott"} } , "tablingMemberConstituency" : {"_value" : "Hackney North and Stoke Newington"} , "tablingMemberPrinted" : [{"_value" : "Ms Diane Abbott"} ], "uin" : "215370"} , {"_about" : "http://data.parliament.uk/resources/157004", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/157004/answer", "answerText" : {"_value" : "

Information on the number and net ingredient cost of prescription items for paracetamol1<\/sup> dispensed in the community in England is in the table.<\/p>

<\/p>

<\/p>

<\/p>

Year<\/p><\/td>

Prescription Items<\/p>

(000s)<\/p><\/td>

Net Ingredient Cost<\/p>

(£000s)<\/p><\/td><\/tr>

2012-13<\/p><\/td>

21,963.2<\/p><\/td>

73,793.9<\/p><\/td><\/tr>

2013-14<\/p><\/td>

22,616.5<\/p><\/td>

83,146.6<\/p><\/td><\/tr><\/tbody><\/table>

<\/p>

1<\/sup>Excludes combination medicines. Includes multiple packs per item and a range of formulations, including those produced specific to patient needs<\/p>

<\/p>

Source:<\/em> Prescription Cost Analysis system provided by the NHS Business Services Authority<\/p>

<\/p>

<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2014-11-25", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "215407"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-11-25T17:07:23.74Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-11-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Paracetamol"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what the cost to the public purse was of prescriptions issued for paracetamol in England in each of the last two years; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4002", "label" : {"_value" : "Biography information for Nick de Bois"} } , "tablingMemberConstituency" : {"_value" : "Enfield North"} , "tablingMemberPrinted" : [{"_value" : "Nick de Bois"} ], "uin" : "215406"} , {"_about" : "http://data.parliament.uk/resources/157005", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/157005/answer", "answerText" : {"_value" : "

Information on the number and net ingredient cost of prescription items for paracetamol1<\/sup> dispensed in the community in England is in the table.<\/p>

<\/p>

<\/p>

<\/p>

Year<\/p><\/td>

Prescription Items<\/p>

(000s)<\/p><\/td>

Net Ingredient Cost<\/p>

(£000s)<\/p><\/td><\/tr>

2012-13<\/p><\/td>

21,963.2<\/p><\/td>

73,793.9<\/p><\/td><\/tr>

2013-14<\/p><\/td>

22,616.5<\/p><\/td>

83,146.6<\/p><\/td><\/tr><\/tbody><\/table>

<\/p>

1<\/sup>Excludes combination medicines. Includes multiple packs per item and a range of formulations, including those produced specific to patient needs<\/p>

<\/p>

Source:<\/em> Prescription Cost Analysis system provided by the NHS Business Services Authority<\/p>

<\/p>

<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2014-11-25", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "215406"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-11-25T17:07:23.85Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-11-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Paracetamol"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, how many prescriptions have been issued for paracetamol in England in each of the last two years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4002", "label" : {"_value" : "Biography information for Nick de Bois"} } , "tablingMemberConstituency" : {"_value" : "Enfield North"} , "tablingMemberPrinted" : [{"_value" : "Nick de Bois"} ], "uin" : "215407"} ], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2014-11-20&_page=1&AnsweringBody.=Department%20of%20Health&_properties=answer.isMinisterialCorrection,tablingMember.label,tablingMember,date,hansardHeading&max-date=2019-05-21&_sort=-tablingMemberConstituency&max-answer.dateOfAnswer=2019-05-21", "page" : 0, "startIndex" : 1, "totalResults" : 22, "type" : "http://purl.org/linked-data/api/vocab#Page"} }